Adzenys Xr-odt Tablet, Orally Disintegrating
Pricing Report NDC 70165-010-30

Current NADAC: $19.20888 per EA · Effective Sep 23, 2026 · Est. package price $3,457.60 (180 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Adzenys Xr-odt (NDC 70165-010-30) is $19.20888 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human prescription drug provided by Neos Therapeutics Brands, Llc, this medication is distributed in a 30 BLISTER PACK in 1 CARTON / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$19.20888
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Sep 23, 2026
Billable Units
180 EA
Estimated Package Price
$3,457.60
Data Status
As of Oct 07, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
70165-010-30
Description
30 BLISTER PACK in 1 CARTON / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Generic Benchmark
The generic equivalent rate is $16.07321 (Effective: Sep 23, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2016, the NADAC wholesale price for (NDC ) has moved within a range of $8.65893 to $19.38557 per EA. Over this 9 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$8.6589 - $19.3856
Market Volatility
123.88% Variance
Latest Trend
0.12%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $19.20888 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $19.23132 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $19.19825 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $19.27135 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $19.25344 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $19.33840 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $19.37374 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $19.38557 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $19.36485 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $19.37588 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 01, 2025 $19.27102 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Aug 01, 2025 $19.27102 EAC/I - Chain or Independent PharmacyCode 3B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026